JAK-STAT inhibitor as a potential therapeutic opportunity in AML patients resistant to cytarabine and epigenetic therapy
JAK-STAT 抑制剂为对阿糖胞苷和表观遗传疗法有耐药性的 AML 患者提供了潜在的治疗机会
期刊:Cancer Biology & Therapy
影响因子:4.4
doi:10.1080/15384047.2020.1831371
Govind Babu, Padmaparna Chaudhuri, Manoj Rajappa, Manjusha Biswas, Bipinesh Sansar, Chethan Rajegowda, Aneesha Radhakrishnan, Jayshree Advani, Biplab Tewary, Padhma Radhakrishnan, Saravanan Thiyagarajan, Aditi Chatterjee, Ram Shankar Upadhayaya, Pradip K Majumder